David Nicholson - Gilde Healthcare

team
Venture&Growth

All team members
David Nicholson
Operational Partner
United States of America

David Nicholson

Operational Partner

David Nicholson is a recognized leader in Pharmaceutical R&D. Most recently he served as Executive Vice President and Chief R&D Officer of Allergan. Previously, he served as Chief Technology Officer and EVP, R&D for a division at Bayer; Vice President of Licensing and Knowledge Management at Merck; and Senior Vice President, responsible for Global Project Management and Drug Safety at Schering-Plough. From 1988 to 2007, Dr. Nicholson held various leadership positions at Organon, where he most recently served as Executive Vice President, Research & Development and was a member of the company’s Executive Management Committee. He received a B.Sc. from the University of Manchester and his Ph.D. from the University of Wales.

Stefan Luzi

Partner Therapeutics
Venture&Growth
Stefan Luzi joined Gilde Healthcare in 2015. He is focusing on venture and growth capital investments in the biopharmaceutical sector. He led several investments and currently represents Gilde on the boards of Lava Therapeutics B.V....

Pieter van der Meer

Managing Partner
Pieter van der Meer is founder and managing partner of Gilde Healthcare. Pieter joined Gilde in 1998 following a consultant position with KPMG Management Consulting. He is co-responsible for general management, the investment committees and...

Susana Amorim

Senior Associate Healthtech
Venture&Growth
Susana Amorim joined Gilde in 2021 and focuses on the Healthtech sector. She is involved in deal sourcing, investment diligence, and portfolio management. Prior to joining Gilde, Susana was a Biodesign Innovation fellow at Stanford University, a...